Parkside Financial Bank & Trust’s Maravai LifeSciences MRVI Stock Holding History

Parkside Financial Bank & Trust’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-95	Closed	-$210	–	2907
2025 Q1	$210	Buy	+95	New	+$375	﹤0.01%	2672
2024 Q2	–	Sell	-287	Closed	-$2.49K	–	2080
2024 Q1	$2.49K	Buy	287 +33	+13%	+$223	﹤0.01%	1480
2023 Q4	$1.66K	Buy	254 +74	+41%	+$478	﹤0.01%	1529
2023 Q3	$1.8K	Buy	+180	New	+$1.98K	﹤0.01%	1693
2022 Q3	–	Sell	-481	Closed	-$14K	–	1888
2022 Q2	$14K	Hold	481	–	–	﹤0.01%	906
2022 Q1	$17K	Sell	481 -87	-15%	-$2.92K	﹤0.01%	874
2021 Q4	$24K	Sell	568 -585	-51%	-$23.7K	0.01%	756
2021 Q3	$57K	Buy	1,153 +729	+172%	+$35.6K	0.02%	468
2021 Q2	$18K	Buy	+424	New	+$16.4K	0.01%	804

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Parkside Financial Bank & Trust's MRVI Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 95 shares — an estimated $210 sold.

Parkside Financial Bank & Trust first reported a position in MRVI in Q2 2021 and held it in 9 quarters. The position peaked at $57K in Q3 2021. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

Parkside Financial Bank & Trust reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
Parkside Financial Bank & Trust sold 95 Maravai LifeSciences shares in Q2 2025, an estimated $210.
Parkside Financial Bank & Trust first reported a position in Maravai LifeSciences in Q2 2021 and held it in 9 quarters.
Parkside Financial Bank & Trust's Maravai LifeSciences position peaked at $57K in Q3 2021.
150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.